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Background: Obstructive sleep apnoea (OSA) is a common disorder that may affect at least 2 to 4% of the adult 
population. Nasal-Continuous Positive Airway Pressure (N-CPAP) is today considered the gold standard for the 
treatment of OSA.
The development of oral appliances (OAs) represents a new approach for the management of this pathology.
The aim of this systematic review is to compare the efficacy of OAs and N-CPAP in the treatment of patients with 
mild to severe OSA.
Material and Methods: A PubMed-MEDLINE and Cochrane databases search of articles published between 1982 
and 2016 comparing the effect of N-CPAP and OAs in OSA patients was conducted during July 2016. The stud-
ies were selected and stratified according to PRISMA and SORT criteria. The main outcome measure was post-
treatment Apnoea-Hypopnoea Index (AHI) while secondary outcomes included post-treatment Epworth Score 
Scale (ESS) score and lowest Oxygen Saturation level.
Results: N-CPAP was significantly more effective in suppressing AHI than OA. Moreover,
N- CPAP was significantly more effective in increasing post-treatment lowest Oxygen Saturation level than OA. 
However, no significant different in decreasing ESS values was found between the two treatments. 
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Conclusions: On the basis of evidence in this review it would appear appropriate to offer OA therapy to those who 
are unwilling or unable to persist with CPAP therapy. N-CPAP still must be considered the gold standard treatment 
for OSA and, therefore, OAs may be included in the list of alternative options.
Key words: CPAP, obstructive sleep apnoea, oral appliances.
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Obstructive Sleep Apnoea (OSA) is a common disorder 
that may affect at least 2 to 4% of the adult population 
(1). The management of OSA depends on the severi-
ty of symptoms and aetiology of airway obstruction. 
Among the treatment options there are some conserva-
tive measures such as weight reduction, relief of nasal 
obstruction and avoidance of alcohol. However, the 
use of Nasal-Continuous Positive Airway Pressure (N-
CPAP), which is considered the gold standard for the 
treatment of OSA, is necessary in the majority of cases 
(2). N-CPAP is effective in treating OSA by “splinting” 
the airway via creation of a positive pressure applied 
through the nares (3).
Recently, the scientific community has been orientating 
towards alternatives to N-CPAP considering the low ad-
herence to treatment and the patients’ low level of satis-
faction.
Today Oral Appliances (OAs) and several surgical tech-
niques can be considered satisfactory options for OSA 
treatment.
The development of OAs represents a new approach for 
the management of OSA (4). An OA is a device that fits 
within the oral cavity and prevents upper airway collap-
se occurring in OSA patients by advancing the mandible 
and, therefore, increasing the upper airways diameters. 
For patients with severe OSA, a trial of N-CPAP is re-
quired prior to their use, and surgery may be preferred 
over an OA for N-CPAP failures. Moreover, predicting 
which patients will have successful OA titration and 
treatment response is still difficulty (5).
A recent American Academy of Sleep Medicine (AASM) 
guideline concluded that OAs are less effective than N-
CPAP but are a reasonable alternative for patients with 
mild to moderate OSA (6).
However, the studies used to establish these guidelines 
are limited by small sample sizes, select patient popula-
tions, the absence of device titration during polysomno-
graphy and there are few data concerning the compari-
son between N-CPAP and OA in patients with OSA.
The aim of this systematic review is to compare the 
efficacy of OA and N-CPAP in the treatment of patients 
with mild to severe OSA.
��������� ��� ���h���
-Literature search protocol 
A PubMed-MEDLINE and Cochrane databases search 
of articles published between 1982 and 2016 was con-
ducted during July 2016. In an initial search, the terms 
“oral appliance”, “nasal-continuous positive airway 
pressure”, “obstructive sleep apnoea” were used. Search 
was limited to human studies, and articles written in En-
glish. The terms were then merged in a second search, 
using the Boolean operator “AND”, in order to obtain 
the articles that included two or more of the used search 
terms. Items founds were analysed to verify the relevan-
ce of these in relation to the topic under study. The irre-
levant articles were discarded. 
The PRISMA criteria were used to select the studies (7) 
The inclusion criteria were: Randomized controlled 
trials (RCT) and RCT crossover comparing N-CPAP to 
Mandibular Advancement Devices (MADs), patients 
affected by mild to severe OSA, patients who were not 
treated previously, studies reporting pre-treatment and 
post-treatment Apnoea-Hypopnoea Index (AHI) values.
Next, the items were stratified according to their level of 
scientific evidence, using the PRISMA criteria. Finally, 
the SORT criteria (Strength of Recommendation Taxo-
nomy) (Tables 1,2) were used to check the level of scien-
tific evidence of the included studies (8). Subsequently, 
according to the level of scientific evidence of the re-
viewed articles, a recommendation level was declared in 
favour of, or against the OA or N-CPAP.
-Outcome measurements
The primary outcome was the post-treatment AHI va-
lue.
The secondary outcomes were the post-treatment 
Epworth Score Scale (ESS) score and lowest Oxygen 
Saturation level.
AHI and lowest Oxygen Saturation level are two ob-
jective outcomes extracted from the polysomnography, 
which is the most important diagnostic tool for the eva-
luation of patients affected by OSA. On the other hand, 
ESS score is a subjective outcome obtained from a ques-
tionnaire used to measure the daytime sleepiness.
-Analysis protocol
Data from the studies were first extracted and assessed 
by the principal investigator (GC), and thereafter inde-
pendently by the co-author (CG) using standardized data 
forms. Articles were examined for data resolution with 
the intent to perform a meta-analysis.
Data extraction included the following items:
1. Population: age, number of patients studied, and 
treatment duration.
2. Intervention: OA (type MAD)
3. Control: N-CPAP
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S����gh �f R������������� Definition
A Recommendation based on consistent and good-quality, 
patient-oriented evidence (1)
B Recommendation based on inconsistent or limited-quality, 
patient-oriented evidence (1)
C Recommendation based on consensus, usual practice, 
opinion, disease-oriented evidence (2), or on case series for 
studies or diagnosis, treatment, prevention or screening
(1) Patient-oriented evidence considers the following 
objectives: reduction of mortality and morbidity, 
improvement o symptoms, better quality of life, reduced 
costs.
(2) Disease-oriented evidence comprises intermediate, 
histopathologic, physiologic and other surrogate for im-
proving the patient’s quality of life (blood sugar, blood 
pressure, etc.) the may or not reflect the patient’s actual 
improvement).
T���� 1: SORT Criteria (Strength of Recommendation Taxonomy) (8).
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T���� 2: Levels of scientific evidence (8).
Abbreviations: SR= systematic review; RCT= randomized clinical trial.
4. Outcomes: as above
5. Design: method of randomisation and allocation con-
cealment
-Assessment of risk of bias in included studies
Different methods of meta-analyses were considered in 
reviewing the literature to seek results that would provi-
de meaningful analysis with the least risk of introducing 
biases. The Quality Assessment of Studies (QUADAS-2) 
tool was used to evaluate relevant study design charac-
teristics of the included studies. This type of quality as-
sessment was designed in 2003 and updated in 2011 to 
help judge the risks of bias and applicability (9).
-Statistical analysis
Random effect models were used to generate pooled 
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estimates. Data were analysed using generic inverse 
radiance method and p<0.05 is regarded as statistically 
significant.
Combined summary statistics of the standardized (STD) 
paired difference in mean for the individual studies are 
shown. Combined STD paired differences in means 
were calculated and a two-sided p value<0.05 was con-
sidered to indicate statistical significance. A 2-based test 
of homogeneity was performed and the inconsistency 
index (I2) statistic was determined. If I2 was 50 or 75 
%, the studies were considered to be heterogeneous or 
highly heterogeneous, respectively. If I2 was below 25 
%, the studies were considered to be homogeneous. If 
the I2 statistic (>50 %) indicated that heterogeneity exis-
ted between studies, a random-effects model was calcu-
lated.
We have used the different comparisons to display the 
results. Subgroup analysis by severity of OSA was not 
possible due to the heterogeneous populations recruited 
in the studies. 
Data from crossover studies have been analysed as pa-
rallel and crossover group data as the trialists made first 
arm data available upon request. 
Publication bias was also tested using the funnel plot. 
A funnel plot is a type of scatter plot that can be use-
ful to understand study heterogeneity of meta-analysis. 
The funnel plot examines the sample size on the y axis 
(plotted as the standard error of the log odds ratio) and 
treatment effect on the x -axis (plotted as the odds ra-
tio).
Analyses were performed with RevMan (Nordic Co-
chrane Center, Copenhagen, Denmark).
F�g. 1: PRISMA diagram showing the systematic review process.
R������
Following the initial analysis, a total of 6 articles were 
selected and included in the study. These items were 
stratified by level of scientific evidence, using the SORT 
criteria (8). All the articles showed a level of evidence 2 
and strenght of recommendation B. 
The search was performed in July 2016 and yielded 140 
articles, of which six articles met inclusion’s criteria (2; 
10-14) (Fig. 1). The graphical display of QUADAS-2 
shows that while the applicability of these studies is very 
high, there is a risk on bias when considering patient 
selection and the flow of the studies (Fig. 2). 
Tables 3 and 4 show data about the type of study, year 
of publication, number of publication, treatment dura-
tion, age, body mass index (BMI), pre-treatment AHI, 
lowest Oxygen Saturation level and ESS. Four studies 
were RCT-crossover while two were RCT. Ferguson and 
Barnes report on longer treatment duration in compari-
son with the other studies (≥6 months).
AHI
CPAP was significantly more effective in suppressing 
AHI than MAD. No heterogeneity was highlighted in 
this analysis (Fig 3).
Lowest Oxygen Saturation level
CPAP was significantly more effective in increasing post-
treatment lowest Oxygen Saturation level than MAD. No 
heterogeneity was highlighted in this analysis (Fig 3).
ESS
No significant different in decreasing ESS values was 
found between the two treatments. A low grade of hete-
rogeneity was registered. However, MADs seem to gua-
rantee slightly better outcomes (Fig 3).
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F�g. 2: Graphical display of QUADAS-2.
D���������
Today, N-CPAP is considered the gold standard treatment 
for OSA patients, being the most evidence based suppor-
ted therapeutic option in the scientific literature. Other 
treatments such as surgery and OAs have been subse-
quently introduced in the armamentarium of sleep medi-
cine but higher evidence is needed to confirm the promi-
sing results presented by many authors.
In this study, meta-analysis of the outcomes of three 
items (AHI, ESS, lowest Oxygen Saturation level) was 
performed to compare the effectiveness of MADs with 
N-CPAP for the treatment of OSA patients. 
Although the number of eligible studies was low, these 
were RCT studies of high-quality evidence. However, 
the blinding of patients or assessors was impossible con-
sidering the different shape of OAs and N-CPAP. Thus, 
blinding was absent in this study decreasing the eviden-
ce grade.
Taking account that four of the included studies were 
RCT crossover and that the duration of treatment 
was different among the studies the following can be 
highlighted.
As a result of the analysis, a more significant decrease 
in AHI was observed in patients treated with N-CPAP. 
Moreover, N-CPAP increased lowest Oxygen Saturation 
level more significantly than OAs.
Finally, although the ESS score was lower after OA the-
rapy in comparison with N-CPAP, no significant diffe-
rence was observed. 
The results of our study were almost similar to those 
of other reviews underlying the role of N-CPAP as first 
choice treatment for OSA patients (15,16).
Despite the better results obtained with N-CPAP, other 
aspects deserve attention.
For instance, a study on the degree of patient satisfaction 
showed better outcomes in patients treated with OAs 
(17). Other studies compared the frequency of use bet-
ween OA and CPAP and showed that the OA was used 
for a longer time (10,17). 
Adherence to treatment has always been a main issue for 
N-CPAP therapy. 
Evidence suggests that use of CPAP for longer than 6 
hours decreases sleepiness, improves daily functioning, 
and restores memory to normal levels (18).   
For this reason, the scientific community has been re-
cently focusing on treatment alternatives such as OAs 
and surgeries, which are preferred by patients and, in 
case of a surgical choice, do not present problems of ad-
herence.
In the studies included in a Cochrane meta-analysis, va-
rious types of OAs were used, such as mandibular ad-
vancement devices, tongue-retaining devices and those 
that allowed mouth opening and limited mouth-opening 
devices (15). On the other hand, our study focused on the 
comparison between MADs and N-CPAP, this allowing 
a more homogeneous analysis.
Various studies have been conducted on the shape of 
the OA. Regarding this aspect, MADs were reported to 
be more effective than tongue-retaining devices (TRD) 
(19).  Other studies have shown that OAs allowing ti-
tratable mandibular advancement and preventing mouth 
opening may be more effective for the treatment of OSA 
(20,21). 
The cost of OAs and their side-effects/complications 
also need to be mentioned. 
Both treatment options may lead to different adverse 
effects (2,13). Jaw and oral pain generally occur more 
frequently with OA than with N-CPAP (15). Other stu-
dies reported higher rates of excessive salivation and 
appliance removal during sleep with OA, but higher ra-
tes of leak, dry upper airway, stuffy nose, and inconve-
nience with N-CPAP (15).
Unfortunately, data on long-term complications and 
costs in patients treated with OAs and N-CPAP are li-
mited. Furthermore, cost-effectiveness analysis may be 
needed to support the role of OAs as an alternative to 
N-CPAP for OSA patients.
Finally, from the current scientific evidence it seems that 
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F�g. 3: Forest plot comparing the effect of N-CPAP and Mandibular Advancement Device (MAD) on the post-treatment Apnoea-Hy-
popnoea Index (AHI) (top). Forest plot comparing the effect of CPAP and MAD on the post-treatment lowest Oxygen Saturation level 
(middle). Forest plot comparing the effect of CPAP and MAD on the post-treatment Epworth Score Scale (ESS) (bottom).
the treatment of OSA needs to be tailored for each pa-
tients. For instance, patients with nasal obstruction cau-
sed by septal deviation or poliposis may not benefit from 
the use of N-CPAP while patients affected by disorder of 
the temporo-mandibular joint may worsen when using 
OAs. 
A holistic evaluation of OSA patients is mandatory be-
fore choosing the most appropriate treatment: upper 
airways anatomy, sleep physiology and metabolic status 
need to be assessed in detail in order to select the best 
candidate, especially when alternatives to N-CPAP are 
taken into consideration.
On the basis of evidence in this review it would appear 
appropriate to offer OA therapy to those who are unwi-
lling or unable to persist with N-CPAP therapy. N-CPAP 
still must be considered the gold standard treatment for 
OSA and, therefore, OAs may be included in the list of 
alternative options. This recommendation is drawn from 
evidence of limited duration. Long-term effects of these 
two treatments are not currently evaluable.
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